scispace - formally typeset
E

Eduardo Arana-Rueda

Researcher at Services Hospital

Publications -  67
Citations -  286

Eduardo Arana-Rueda is an academic researcher from Services Hospital. The author has contributed to research in topics: Catheter ablation & Pulmonary vein. The author has an hindex of 7, co-authored 66 publications receiving 236 citations.

Papers
More filters
Journal ArticleDOI

Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study.

TL;DR: First-line endoepicardial VT substrate ablation achieves good long-term results in AC and left-dominant AC is associated with an increased risk of recurrence, and the Bi/Uni-LVA ratio identifies patients with limited epicardial arrhythmogenic substrate in whom the indication of epicardian approach should be more cautiously assessed.
Journal ArticleDOI

Paroxysmal atrial fibrillation burden before and after pulmonary veins isolation: an observational study through a subcutaneous leadless cardiac monitor.

TL;DR: The aim is to describe the outcome of pulmonary vein isolation in paroxysmal AF through a subcutaneous cardiac monitor (ICM) implanted before the procedure to evaluate the efficacy of ablation considering the AF burden.
Journal ArticleDOI

Impact of Contact Force Monitoring in Acute Pulmonary Vein Isolation Using an Anatomic Approach. A Randomized Study

TL;DR: This work analyzes the usefulness of CF monitoring in acute PV isolation and procedure parameters using a CAA to determine contact force monitoring in pulmonary vein (PV) isolation after a circumferential anatomic ablation.
Journal ArticleDOI

Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.

TL;DR: Rates of cardiac‐device infections have increased in recent years, but the current incidence and risk factors for infection in patients with implantable cardioverter‐defibrillators (ICDs) are not well known.